Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HEALTHEQUITY, INC. (HQY)
|
Add to portfolio |
|
|
|
| Price: |
$46.84
| | Metrics |
| OS: |
85.5
|
M
| |
|
|
| Market cap: |
$4
|
B
| |
|
|
|
Net debt:
|
$647
|
M
| |
2.9
|
x Debt/EBITDA
|
|
EV:
|
$4.65
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$223
|
M
| |
20.9
|
x EV/EBITDA
|
|
EBIT
|
$62.3
|
M
| |
74.7
|
x EV/EBIT
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jan-31-23 | Jan-31-22 | Jan-31-21 | Jan-31-20 | Jan-31-19 | Jan-05-19 | Jan-31-18 | Jan-31-17 |
| Revenues | 861.7 | 756.6 | 733.6 | 532.0 | 287.2 | 287.2 | 229.5 | 178.4 |
| Revenue growth | 13.9% | 3.1% | 37.9% | 85.2% | 25.1% | | 28.7% | 40.7% |
| Cost of goods sold | 371.7 | 332.9 | 394.3 | 240.8 | 112.0 | 106.1 | 99.5 | 76.3 |
| Gross profit | 490.1 | 423.7 | 339.3 | 291.2 | 175.3 | 181.2 | 130.1 | 102.1 |
| Gross margin | 56.9% | 56.0% | 46.2% | 54.7% | 61.0% | 63.1% | 56.7% | 57.2% |
| Sales and marketing | 68.8 | 58.6 | 50.0 | 44.0 | 29.5 | 29.5 | 23.1 | 18.3 |
| Research and development | 193.4 | 157.4 | 124.8 | 77.6 | 35.1 | 35.1 | 27.4 | 22.4 |
| General and administrative | 95.6 | 84.4 | 84.5 | 60.6 | 33.0 | 33.0 | 25.1 | 20.2 |
| EBITA | 132.2 | 123.4 | 179.9 | 155.6 | 92.4 | 83.6 | 67.6 | 52.4 |
| EBITA margin | 15.3% | 16.3% | 24.5% | 29.3% | 32.2% | 29.1% | 29.5% | 29.4% |
| Amortization of intangibles | 94.6 | 82.8 | 99.9 | 46.5 | 14.7 | 5.9 | 13.2 | 11.2 |
| EBIT | 37.7 | 40.6 | 80.0 | 109.1 | 77.7 | 77.7 | 54.4 | 41.2 |
| EBIT margin | 4.4% | 5.4% | 10.9% | 20.5% | 27.0% | 27.0% | 23.7% | 23.1% |
| Pre-tax income | 0.0 | 0.0 | 4.1 | 43.2 | 75.8 | 75.8 | 52.2 | 40.1 |
| Income taxes | -12.0 | -22.5 | -4.7 | 3.5 | 1.9 | 1.9 | 4.8 | 13.7 |
| Tax rate | | | | 8.1% | 2.5% | 2.5% | 9.2% | 34.3% |
| Net income | 0.0 | 0.0 | 8.8 | 39.7 | 73.9 | 73.9 | 47.4 | 26.4 |
| Net margin | 0.0% | 0.0% | 1.2% | 7.5% | 25.7% | 25.7% | 20.6% | 14.8% |
| |
| Diluted EPS | | | $0.12 | $0.58 | $1.17 | $1.17 | $0.77 | $0.44 |
| Shares outstanding (diluted) | | | 75.7 | 68.5 | 63.4 | 63.4 | 61.9 | 59.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|